Company Registration No. 13258442 (England and Wales)
ROCK N ROE BLUE MED LTD
Unaudited accounts
for the year ended 31 March 2025
ROCK N ROE BLUE MED LTD
Unaudited accounts
Contents
ROCK N ROE BLUE MED LTD
Company Information
for the year ended 31 March 2025
Company Number
13258442 (England and Wales)
Registered Office
40 WILLOUGHBY ROAD
LONDON
N8 0JG
ENGLAND
ROCK N ROE BLUE MED LTD
Statement of financial position
as at 31 March 2025
Tangible assets
6,512
8,140
Cash at bank and in hand
9,931
15,602
Creditors: amounts falling due within one year
(18,877)
(11,227)
Net current (liabilities)/assets
(4,998)
4,588
Called up share capital
100
100
Profit and loss account
1,414
12,628
Shareholders' funds
1,514
12,728
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 11 December 2025 and were signed on its behalf by
Behic Osman
Director
Company Registration No. 13258442
ROCK N ROE BLUE MED LTD
Notes to the Accounts
for the year ended 31 March 2025
ROCK N ROE BLUE MED LTD is a private company, limited by shares, registered in England and Wales, registration number 13258442. The registered office is 40 WILLOUGHBY ROAD, LONDON, N8 0JG, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20% reducing balance method
Fixtures & fittings
20% reducing balance method
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to known amount of cash and are subject to an insignificant risk of change in value.
The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
ROCK N ROE BLUE MED LTD
Notes to the Accounts
for the year ended 31 March 2025
Expenses are recognized in the period in which they are incurred, regardless of when payment is made.
The Director has reasonable expectation that the Company will have adequate resources to continue in operational existence for the foreseeable future. The Company therefore continue to adopt the Going Concern basis for preparing it's financial statements.
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
4
Tangible fixed assets
Plant & machinery
Fixtures & fittings
Total
Cost or valuation
At cost
At cost
At 1 April 2024
8,032
7,865
15,897
At 31 March 2025
8,032
7,865
15,897
At 1 April 2024
3,919
3,838
7,757
Charge for the year
822
806
1,628
At 31 March 2025
4,741
4,644
9,385
At 31 March 2025
3,291
3,221
6,512
At 31 March 2024
4,113
4,027
8,140
Amounts falling due within one year
6
Creditors: amounts falling due within one year
2025
2024
Taxes and social security
7,167
7,711
Loans from directors
10,651
3,516
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
ROCK N ROE BLUE MED LTD
Notes to the Accounts
for the year ended 31 March 2025
8
Average number of employees
During the year the average number of employees was 4 (2024: 3).